Exact Sciences CORP Form 4 insider transactions

Exact Sciences EVP Brian Baranick sold 2,858 shares of common stock for $70.08 per share under a pre-arranged trading plan.

Exact Sciences Director Katherine S. Zanotti sold 12,000 shares of common stock for $65 per share, reducing her direct beneficial ownership to 60,759 shares.

Exact Sciences' SVP, General Counsel & Secretary, James Herriott, sold 1,500 shares of common stock for $60 per share under a pre-arranged trading plan.

EXACT Sciences Director James Edward Doyle sold 2,000 shares of common stock for $60 per share on October 9, 2025, pursuant to a pre-arranged 10b5-1 trading plan.

Exact Sciences Director James Doyle sold 1,485 shares of common stock for $42.02 per share under a pre-arranged 10b5-1 trading plan.

Exact Sciences EVP Jacob Orville reported the vesting of restricted stock units and subsequent tax-related share withholding.

Exact Sciences EVP Brian Baranick reported the vesting of restricted stock units and subsequent share disposition for tax purposes.

Exact Sciences Corporation Director James Edward Doyle was granted 5,398 shares of common stock as part of the company's non-employee director compensation policy, increasing his total beneficial ownership to 61,447 shares.

Exact Sciences Corp. Director Michael J. Barber reported the acquisition of 7,197 shares of common stock as part of the company's non-employee director compensation policy, increasing his total beneficial ownership to 13,136 shares.

Exact Sciences Corporation's Director, Paul J. Clancy, has acquired 5,398 shares of common stock as part of the company's non-employee director compensation policy.

Exact Sciences Corp. Director Kimberly J. Popovits acquired 9,994 shares of common stock on June 12, 2025, as part of the company's non-employee director compensation policy.

Exact Sciences Corp. Director Leslie Trigg was granted 7,670 shares of common stock as part of the company's non-employee director compensation policy.

Exact Sciences Corporation Director Shacey Petrovic acquired 5,398 shares of common stock on June 12, 2025, as part of the company's non-employee director compensation policy, increasing her direct beneficial ownership to 21,804 shares.

Exact Sciences Corp. Director Katherine S. Zanotti reported the acquisition of 5,398 shares of common stock as compensation and the subsequent sale of 3,207 shares under a pre-arranged Rule 10b5-1 trading plan.

Exact Sciences Corporation's Director, Daniel J. Levangie, was granted 5,398 shares of common stock as part of the company's non-employee director compensation policy, increasing his beneficial ownership to 34,312 shares.

Exact Sciences Corporation's Director, D. Scott Coward, was granted 5,398 shares of common stock on June 12, 2025, as part of the company's non-employee director compensation policy.

James Herriott, SVP, General Counsel & Secretary of Exact Sciences Corp, reports acquisition of common stock and restricted stock units.

Director Leslie Trigg of Exact Sciences Corp. reports acquisition of shares through a restricted stock award and subsequent holdings.

EVP and CFO Aaron Bloomer reports stock transactions involving the vesting and tax withholding of restricted stock units.

CEO Kevin Conroy of Exact Sciences Corp. reports exercising stock options and subsequent share withholding to cover exercise price and taxes, resulting in a net increase in share holdings.

James Herriott, SVP, General Counsel & Secretary of Exact Sciences Corp, reports transactions involving common stock and restricted stock units.

CEO Kevin Conroy reports transactions involving Exact Sciences Corp. common stock and restricted stock units.

EVP and GM of Precision Oncology at Exact Sciences, Brian Baranick, reports the vesting of restricted stock units and subsequent stock transactions for tax withholding.

EVP Jacob A. Orville reports stock transactions related to vesting of restricted stock units.

Sarah Condella, EVP of Human Resources at Exact Sciences, reports stock transactions including acquisition of shares from vested restricted stock units, disposal of shares for tax withholding, and a gift of shares.

Aaron Bloomer, EVP and CFO of Exact Sciences, reports the acquisition of 28,779 restricted stock units (RSUs) on February 24, 2025, according to a Form 4 filing.

CEO Kevin Conroy reports acquisition and disposal of Exact Sciences Corp. stock and restricted stock units.

Sarah Condella, EVP of Human Resources at Exact Sciences, reports the vesting and disposal of restricted stock units for tax withholding.

Brian Baranick, EVP, GM, Precision Oncology at Exact Sciences Corp, reports the vesting and disposal of restricted stock units for tax purposes.

James Herriott, SVP, General Counsel & Secretary of Exact Sciences Corp, reports acquisition and disposal of common stock and restricted stock units.